UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients

The New England journal of medicine, 2004-07, Vol.351 (5), p.438-450

2004

Volltextzugriff (PDF)

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

Hepatology (Baltimore, Md.), 2006-06, Vol.43 (6), p.1317-1325

2006

Volltextzugriff (PDF)

Incidence of and Risk Factors for Symptomatic Visceral Leishmaniasis among Human Immunodeficiency Virus Type 1-Infected Patients from Spain in the Era of Highly Active Antiretroviral Therapy

Journal of Clinical Microbiology, 2002-03, Vol.40 (3), p.762-767

2002

Volltextzugriff (PDF)

Influence of Highly Active Antiretroviral Therapy on the Outcome of Subclinical Visceral Leishmaniasis in Human Immunodeficiency Virus-Infected Patients

Clinical infectious diseases, 2001-02, Vol.32 (4), p.633-635

2001

Volltextzugriff (PDF)

Tratamiento de las hepatitis víricas (II). Tratamiento de la hepatitis crónica C

Enfermedades infecciosas y microbiología clínica, 2006, Vol.24 (8), p.518-526

2006

Volltextzugriff (PDF)

Histological response to pegIFNα-2a (40KD) plus ribavirin in HIV–hepatitis C virus co-infection

AIDS (London), 2006-11, Vol.20 (17), p.2175-2181

2006

Volltextzugriff (PDF)

T-cell repopulation and thymic volume in HIV-1–infected adult patients after highly active antiretroviral therapy

Blood, 2002-05, Vol.99 (10), p.3702-3706

2002

Volltextzugriff (PDF)

Hepatic steatosis in HIV/HCV co-infected patients: Correlates, efficacy and outcomes of anti-HCV therapy: A paired liver biopsy study

Journal of hepatology, 2008-05, Vol.48 (5), p.756-764

2008

Volltextzugriff (PDF)

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

Journal of hepatology, 1997, Vol.26 (1), p.1-5

1997

Volltextzugriff (PDF)

Regression of Invasive AIDS-Related Kaposi's Sarcoma Following Antiretroviral Therapy

Clinical infectious diseases, 1998-01, Vol.26 (1), p.218-219

1998

Volltextzugriff (PDF)

Histological response to pegIFN alpha -2a (40KD) plus ribavirin in HIV-hepatitis C virus co-infection

AIDS (London), 2006-11, Vol.20 (17), p.2175-2181

2006

Volltextzugriff (PDF)

Primary Cutaneous Cryptococcosis of the Penis

Sexually transmitted diseases, 2012-10, Vol.39 (10), p.792-793

2012

Volltextzugriff (PDF)

Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infection

AIDS (London), 2007-07, Vol.21 (12), p.1555-1559

2007

Volltextzugriff (PDF)

Tratamiento de las hepatitis víricas (I). Tratamiento de la hepatitis crónica B

Enfermedades infecciosas y microbiología clínica, 2006, Vol.24 (7), p.453-462

2006

Volltextzugriff (PDF)

Endogenous IL-7 is associated with increased thymic volume in adult HIV-infected patients under highly active antiretroviral therapy

AIDS (London), 2003-05, Vol.17 (7), p.947-954

2003

Volltextzugriff (PDF)

Human immunodeficiency virus and hepatitis C virus co-infection. Do we know its clinical course in the HAART era?

Medicina clínica, 2003-10, Vol.121 (11), p.410-411

2003

Volltextzugriff (PDF)

Coinfección por el virus de la inmunodeficiencia humana y el virus de la hepatitis C. ¿Se conoce su historia natural en la era del TARGA?

Medicina clínica, 2003, Vol.121 (11), p.410-411

2003

Volltextzugriff (PDF)

Treatment of viral hepatitis (I). Treatment of chronic hepatitis B

Enfermedades infecciosas y microbiología clínica, 2006-08, Vol.24 (7), p.453-61; quiz 462

2006

Volltextzugriff (PDF)

Histological response to pegIFNalpha-2a (40KD) plus ribavirin in HIV-hepatitis C virus co-infection

AIDS (London), 2006-11, Vol.20 (17), p.2175-2181

2006

Volltextzugriff (PDF)

Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries

AIDS (London), 1998-10, Vol.12 (15), p.2007-2015

1998

Volltextzugriff (PDF)

The role of serology in the diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type-1

The American journal of tropical medicine and hygiene, 1998-07, Vol.59 (1), p.155-162

1998

Volltextzugriff (PDF)

Long-term virological outcome and resistance mutations at virological rebound in HIV-infected adults on protease inhibitor-sparing highly active antiretroviral therapy

Journal of antimicrobial chemotherapy, 2004-01, Vol.53 (1), p.95-101

2004

Volltextzugriff (PDF)

High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients

The American journal of tropical medicine and hygiene, 1999-11, Vol.61 (5), p.766-769

1999

Volltextzugriff (PDF)

Disseminate and fatal cytomegalovirus disease with thymitis in a naive HIV-patient after early initiation of HAART: Immune restoration disease?

Journal of clinical virology, 2006-05, Vol.36 (1), p.13-16

2006

Volltextzugriff (PDF)

Prevalence and factors involved in discordant responses to highly active antiretroviral treatment in a closely followed cohort of treatment-naïve HIV-infected patients

Journal of clinical virology, 2005-06, Vol.33 (2), p.110-115

2005

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(57)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(44)
Life Sciences & Biomedicine
(41)
Science & Technology
(41)
Biological And Medical Sciences
(32)
Medical Sciences
(32)
Infectious Diseases
(31)
Adult
(29)
Male
(29)
Female
(28)
Hiv Infections - Drug Therapy
(20)
Virology
(19)
Human Viral Diseases
(18)
Viral Diseases
(18)
Antiretroviral Therapy, Highly Active
(17)
Immunology
(17)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(17)
Aids/hiv
(16)
Hiv Infections - Complications
(16)
Cd4 Lymphocyte Count
(13)
Human Immunodeficiency Virus
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

Incidence of and Risk Factors for Symptomatic Visceral Leishmaniasis among Human Immunodeficiency Virus Type 1-Infected Patients from Spain in the Era of Highly Active Antiretroviral Therapy

Influence of Highly Active Antiretroviral Therapy on the Outcome of Subclinical Visceral Leishmaniasis in Human Immunodeficiency Virus-Infected Patients

Tratamiento de las hepatitis víricas (II). Tratamiento de la hepatitis crónica C

Histological response to pegIFNα-2a (40KD) plus ribavirin in HIV–hepatitis C virus co-infection

T-cell repopulation and thymic volume in HIV-1–infected adult patients after highly active antiretroviral therapy

Hepatic steatosis in HIV/HCV co-infected patients: Correlates, efficacy and outcomes of anti-HCV therapy: A paired liver biopsy study

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

Regression of Invasive AIDS-Related Kaposi's Sarcoma Following Antiretroviral Therapy

Histological response to pegIFN alpha -2a (40KD) plus ribavirin in HIV-hepatitis C virus co-infection

Primary Cutaneous Cryptococcosis of the Penis

Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infection

Tratamiento de las hepatitis víricas (I). Tratamiento de la hepatitis crónica B

Endogenous IL-7 is associated with increased thymic volume in adult HIV-infected patients under highly active antiretroviral therapy

Human immunodeficiency virus and hepatitis C virus co-infection. Do we know its clinical course in the HAART era?

Coinfección por el virus de la inmunodeficiencia humana y el virus de la hepatitis C. ¿Se conoce su historia natural en la era del TARGA?

Treatment of viral hepatitis (I). Treatment of chronic hepatitis B

Histological response to pegIFNalpha-2a (40KD) plus ribavirin in HIV-hepatitis C virus co-infection

Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries

The role of serology in the diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type-1

Long-term virological outcome and resistance mutations at virological rebound in HIV-infected adults on protease inhibitor-sparing highly active antiretroviral therapy

High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients

Disseminate and fatal cytomegalovirus disease with thymitis in a naive HIV-patient after early initiation of HAART: Immune restoration disease?

Prevalence and factors involved in discordant responses to highly active antiretroviral treatment in a closely followed cohort of treatment-naïve HIV-infected patients

Suchergebnisse filtern